Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis

Journal of Neuroimmunology

Volumn 78, Issue 1-2, 1997, Pages 97-107

  Nagra, Rashed M ^b   Becher, Burkhard ^c   Tourtellotte, Wallace W ^b   Antel, Jack P ^c   Gold, Daniel ^a   Paladino, Toni ^d   Smith, Richard A ^e   Nelson, James R ^e   Reynolds, Wanda F ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Neurology Center   (United States)

Author keywords

Alu hormone response elements; Macrophages; Microglia; Multiple sclerosis; Myeloperoxidase

Indexed keywords

MYELOPEROXIDASE;

ARTICLE; CROSS LINKING; CYTOTOXICITY; ENZYME ACTIVITY; GENETIC ANALYSIS; GENOTYPE; HORMONE RESPONSE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ADULT; AGED; DNA, COMPLEMENTARY; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; PEROXIDASE; RNA, MESSENGER;

EID: 0030764896     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00089-1     Document Type: Article

References (43)

1. Bagasra O., Michaels F.H., Zheng Y.M., Bobroski L.E., Spitsin S.V., Fu Z.F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;12041-12045.
2. Bainton D.F., Ullyot J.L., Farquhar M.G. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. Exp. Med. 134:1971;907-934.
3. Becher B., Antel J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia. 18:1996;1-10.
4. Becher B., Fedorovicz V., Antel J.P. Regulation of CD14 expression on human adult CNS-derived microglia. J. Neurosci. Res. 45:1996;375-381.
5. Britten R.J. Evolutionary selection against change in many Alu repeat seuence interspersed through primate genomes. Proc. Natl. Acad. Sci. USA. 91:1994;5992-5996.
6. Daugherty A., Rateri D.L., Dunn J., Heinecke J.W. Myeloperoxidase: A catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:1994;437-444.
7. Canadian Collaborative Study Group, Ebers G.C., Sadovnick A.D., Risch N.J. A genetic basis for familial aggregation in MS. Nature. 377:1995;150-151.
8. Fouret P., du Bois R.M., Bernaudin J.F., Takahashi H., Ferrans V.J., Crystal R.G. Expression of the neutrophil elastase gene during human bone marrow cell differentiation. J. Exp. Med. 169:1989;833-845.
9. Glabinski A., Tawsek N.S., Bartosz G. Increased generation of superoxide radicals in the blood of MS patients. Acta Neurol. Scand. 88:1993;174-177.
10. Halliwell B. Oxygen radicals as key mediators in neurological disease: Fact or fiction? Ann. Neurol. 32s:1992;10-15.
11. Hazen S., Hsu F., Duffin K., Heinecke J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 271:1996;23080-23088.
12. Johnson K.R., Nauseef W.M., Care A., Wheelock M.J., Shane S., Hudson S., Koeffler H.P., Selsted M., Miller C., Rovera G. Characterization of cDNA clones for human myeloperoxidase: Predicted amino acid sequence and evidence for multiple mRNA species. Nucl. Acids Res. 15:1987;2028-2113.
13. Josephy P.D. The role of peroxidase-catalyzed activation of aromatic amines in breast cancer. Mutagenesis. 11:1996;3-7.
14. Klebanoff S.J. Oxygen metabolism and the toxic properties of phagocytes. Ann. Int. Med. 93:1980;480-489.
15. Koeffler H.P., Ranyard J., Pertcheck M. Myeloperoxidase: Its structure and expression during myeloid differentiation. Blood. 65:1985;484-491.
16. Nauseef W.M., Cogley M., McCormick S. Effect of the R569W missense mutation of the biosynthesis of myeloperoxidase. J. Biol. Chem. 271:1996;9546-9549.
17. Nauseef W.M., Root R.K., Malech H.L. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J. Clin. Invest. 71:1983;1297-1307.
18. Norris J., Fan D., Aleman C., Marks J.R., Futreal A., Wiseman R.W., Iglehart J.D., Deininger P.L., McDonnell D.P. Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor dependent transcriptional enhancers. J. Biol. Chem. 271:1995;22777-22782.
19. Pero R.W., Sheng Y., Olsson A., Bryngelsson C., Lund-Pero M. Hypochlorous acid/N-chloramines are naturally produced DNA repair inhibitors. Carcinogenesis. 17:1996;13-18.
20. Petruska J.M., Mosebrook D.R., Jakab G.J., Trush M.A. Myeloperoxidase enhanced formation of trans 7.8 dihydroxibenzo(a)pyrene-DNA adducts in lung tissue in vitro: A role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis. 13:1992;1075-1081.
21. Piedrafita F.J., Molander R., Vansant G., Orlova E.A., Pfahl M., Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271:1996;14412-14420.
22. Ramos C.L., Pou S., Britigan B.E., Cohen M.S., Rosen G.M. Spin trapping evidence for myeloperoxidase dependent hydroxyl radical formation by neutrophils and monocytes. J. Biol. Chem. 267:1992;8307-8312.
23. Reynolds, W.F., Chang, E., Douer, D., Ball, E.D., Kanda, V., 1997. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood (in press).
24. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
25. Sanders V.J., Conrad A., Tourtellotte W.W. On classification of postmortem MS plaques for neuroscientists. J. Neuroimmunol. 46:1993;207-214.
26. Sanders V.J., Waddell A.E., Felisan S.L., Li X., Conrad A.J., Tourtellotte W.W. Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch. Neurol. 53:1996;125-133.
27. Steinman L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
28. Steinman L., Waisman A., Altmann A. Major T-cell responses in multiple sclerosis. Mol. Med. Today. 1:1995;79-83.
29. Talbot P.J., Paquette J.S., Ciurli C., Antel J.P., Ouellet F. Myelin basic protein and human coronavirus 229E cross-reactive T cells in MS. Ann. Neurol. 39:1996;233-240.
30. The Multiple Sclerosis Genetics Group, 1996. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genetics, 13, 469-471.
31. Tobler A., Miller C.W., Johnson K.R., Selsted M.E., Rovera G., Koeffler H.P. Regulation of gene expression of myeloperoxidase during myeloid differentiation. J. Cell. Physiol. 136:1988;215-225.
32. Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., Endo N. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271:1996;6839-6844.
33. Ulvestad E., Williams K., Mork S., Antel J., Nyland H. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J. Neuropathol. Exp. Neurol. 53:1994;492-505.
34. Van Rensburg C.E., Van Staden A.M., Anderson R., Van Rensburg E.J. Hypochlorous acid potentiates hydrogen peroxide-mediated DNA-strand breaks in human mononuclear leucocytes. Mutation Res. 265:1992;255-261.
35. Vansant G., Reynolds W.F. The consensus sequence of a major Alu subfamily contains a functional retinoic acid response element. Proc. Natl. Acad. Sci. USA. 18:1995;8229-8233.
36. Wilson, D.B., Golding, A., Smith, R.A., Dafashy, T., Nelson, J., Smith, L., Carlo, D.J., Brostoff, S.W., Gold, D.P., 1997. Results of a phase I clinical trial of a T-cell receptor peptide vaccine in patients with multiple sclerosis. I. Analysis of T-cell receptor utilization in CSF cell populations. J. Neuroimmunol.
37. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe N.M., Cuzner M.L., Hafler D.A. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86) and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.
38. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-520.
39. Witko-Sarsat V., Allen R., Paulais M., Nguyen A., Bessou G., Lenoir G., Descamps-Latscha B. Disturbed myeloperoxidase dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes and its correction by amiloride. J. Immunol. 157:1996;2728-2735.
40. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T-cell-mediated autoimmunity: Viral peptides activate human T-cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
41. Yamada M., Kurahashi K. Regulation of myeloperoxidase gene expression during differentiation of human myeloid leukemia HL-60 cells. J. Biol. Chem. 259:1984;3021-3025.
42. Yong, V.W., Antel, J.P., 1991. Culture of glial cells from human brain biopsies. In: Protocols for neural cell culture. S. Federoff, A. Richardson.
43. Zaki S.R., Austin G.E., Swan D., Srinivasan A., Ragab A.H., Chan W.C. Human myeloperoxidase gene expression in acute leukemia. Blood. 74:1989;2096-2102.